Columns

Columns
Will New FDA Rules Help Dial Back Expedited Drugs?
By Teresa Carr
04.12.2023
Columns
Why Online Civility Is Hard to Define–and Enforce
By Teresa Carr
08.15.2022
Columns
For ONA, the Thorny Ethics of Partnering With 3M
By Teresa Carr
05.23.2022
Columns
New Research into BLM’s Influence on Policing
By Rod McCullom
05.18.2022
Columns
Peering Inside Social Media’s Black Box
By Teresa Carr
04.18.2022
Columns
New Business Ventures Tackle High Drug Costs
By Teresa Carr
02.21.2022
Columns
The Science of Preventing Flight Disruptions
By Teresa Carr
01.12.2022
Columns
Gender Diversity in Women’s STEM Societies
By Teresa Carr
10.27.2021
Columns
Do Libido-Boosting Drugs for Women Actually Work?
By Teresa Carr
08.11.2021
Columns
Using Police Tasers on Teens: A Dearth of Data
By Rod McCullom
05.05.2021
Columns
Countering Misinformation in the Public Square
By Teresa Carr
05.03.2021
Columns
For Melanoma, a Diagnosis Dilemma
By Teresa Carr
01.25.2021
Columns
Return of the Grinch Bots
By Teresa Carr
11.27.2020
Columns
Mass Incarceration and Covid-19
By Rod McCullom
11.02.2020
Columns
Are Americans Losing Trust in the FDA?
By Teresa Carr
10.14.2020
Columns
Weighing Routine Screening Tests Against Covid-19
By Teresa Carr
08.12.2020
Columns
Did AI worsen Covid-19’s Toll on Black Americans?
By Rod McCullom
07.27.2020
Columns
In Covid-19 Coverage, Female Experts Are Missing
By Teresa Carr
06.22.2020
Prev
About Undark

Truth, Beauty, Science.

Tipsters
Corruption in science? Academic discrimination? Research censorship? Government cover-ups?
Undark wants to hear about it. Email us at [email protected] or visit our contact page for more secure options.
Undark Magazine